頸動脈分流套件市場報告：至2031年的趨勢、預測與競爭分析

全球頸動脈分流術套件市場的未來前景預計將源於醫院和門診手術中心市場的機會。預計在2025-2031年的預測期內，全球頸動脈分流術套件市場的年複合成長率將達到11.7%。該市場的主要促進因素包括頸動脈疾病盛行率的上升、人們對中風預防意識的增強以及外科技術的不斷進步。

• 根據類型，Lucintel 預測傳統分流器在預測期內將經歷高速成長。
• 從應用來看，醫院預計將經歷高速成長。
• 根據地區，預計北美將在預測期內實現最高成長。

頸動脈分流套件市場的新趨勢

頸動脈分流套件市場受到各種新興趨勢的推動，這些趨勢塑造市場格局並決定新產品和新策略。

• 微創手術：微創技術已成為頸動脈分流套件市場的核心趨勢之一。這些手術具有切口小、恢復時間短、併發症少等優點。因此，越來越多的醫療保健提供者選擇支援此類手術的分流套件。患者受益於更快的康復和更低的風險，而醫生則可以改善手術效果。這些發展增加了對專用設備的需求，以迎合微創手術的趨勢。
• 技術創新：分流套件的技術進步，例如即時追蹤和精準度提升，徹底改變市場。先進材料和技術（例如生物可吸收分流器和血流監測感測器）的使用提高手術的成功率。這些技術目的是提高患者安全性並降低併發症風險。隨著技術的進步，市場上出現了更多先進的設備，這些設備不僅可以提高手術效率，還可以改善患者的治療效果，推動整個市場的發展。
• 人口老化：人口老化，尤其是在美國、日本和德國等已開發國家，是頸動脈分流套件市場成長的主要驅動力之一。老年患者由於心血管疾病風險較高，且更有可能需要進行頸動脈手術。由於醫療保健系統需要更多的手術，這個年齡層的患者群體對成功的分流套件的需求不斷成長。未來幾年，人口趨勢可能會繼續推動市場發展。
• 邁向個人化醫療：頸動脈分流套件產業正經歷著向個人化醫療的轉變，即根據每位患者的具體需求量身定做治療方法和設備。個人化分流套件，即根據患者獨特的解剖結構差異而設計的套件，正變得越來越普遍。這種個人化解決方案有助於最大限度地減少併發症，並管理患者的特殊情況，獲得更好的手術效果。影像技術和患者特定資訊的發展也為個人化醫療提供了補充，使醫療專業人員能夠在手術室中做出更明智的決策，並改進治療方案。
• 不斷變化的法規和核准：不斷變化的法規塑造頸動脈分流套件市場。某些市場（例如美國和歐洲）已經收緊了法規，以確保只有最安全、最高效的設備才能獲準使用。相反，中國和印度等市場則迅速獲得了監管部門的核准，並加速了發展。不斷變化的法規要求企業遵守全球標準，推動創新並提高頸動脈分流套件的整體品質和安全性。

這些新興趨勢 - 微創治療、技術進步、人口老化、個人化醫療和監管變化 - 改變頸動脈分流套件市場，隨著持續的技術創新不斷改善患者照護、手術結果和整體市場成長，使其更加充滿活力。

頸動脈分流套件市場的最新趨勢

頸動脈分流術套件市場目前的趨勢表明，人們越來越重視提高頸動脈手術的有效性和安全性。技術進步和監管變革推動先進醫療設備在各個地區的廣泛應用。

• 先進分流套件的推出：近期趨勢推動了採用優質材料和設計的分流套件的開發，最大限度地降低了併發症的風險。分流套件改善了血流調節，耐受性更強，改善了手術效果並縮短了患者康復時間。生物可吸收材料的使用和改進的分流結構顯著降低了感染和血栓栓塞併發症的風險。
• 新興市場的成長：受醫療成本上漲和心血管疾病盛行率上升的推動，頸動脈分流套件市場在中國和印度等新興國家正以驚人的速度成長。各大公司紛紛進入這些國家，為當地市場提供價格更低、性能更佳的設備。這些國家的成長意味著巨大的機會，可以觸及先前服務不足的患者群體。
• 先進的病患監測功能：新型頸動脈分流套件擴大配備即時監測技術。這些技術進步有助於醫護人員在手術過程中監測血液循環，降低併發症發生率並提高手術精準度。這些套件整合了感測器和其他監測系統，還能幫助外科醫生在手術過程中即時進行必要的調整，提高病患安全性。
• 微創手術增加：分流套件技術的進步顯著增加了微創頸動脈手術的數量。這些手術具有恢復更快、併發症更少、整體療效更佳等優點。這導致對用於這些手術的分流套件的需求增加，推動了進一步的產品開發。
• 監管變化與核准：世界各地的監管機構簡化新型頸動脈分流套件的核准程序。這項變化加快複雜產品的上市時間。各公司正與監管機構密切合作，以遵守各國法規，加速產品上市速度並提高設備安全性。

頸動脈分流套件行業的當前趨勢表明，該行業正致力於提高安全性、最大限度地減少併發症，並拓展新的市場覆蓋範圍。這些趨勢徹底改變市場，並透過技術進步推動成長，尤其是在新興經濟體。

目錄

第1章 執行摘要

第2章 全球頸動脈分流套件市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章 2019年至2031年市場趨勢及預測分析

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球頸動脈分流套件市場趨勢（2019-2024年）及預測（2025-2031年）
• 全球頸動脈分流套件市場類型
  • 常規分流器
  • 逆流系統
• 全球頸動脈分流套件市場（依應用）
  • 醫院
  • 門診手術中心
  • 其他

第4章 2019年至2031年區域市場趨勢與預測分析

• 頸動脈分流套件市場（依地區）
• 北美頸動脈分流套件市場
• 歐洲頸動脈分流套件市場
• 亞太頸動脈分流套件市場
• 世界其他地區的頸動脈分流套件市場

第5章 競爭分析

• 產品系列分析
• 運作整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球頸動脈分流套件市場成長機會（依類型）
  • 全球頸動脈分流套件市場成長機會（依應用）
  • 頸動脈分流套件市場的成長機會（依區域）
• 全球頸動脈分流套件市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球頸動脈分流套件市場產能擴張
  • 全球頸動脈分流套件市場的合併、收購與合資企業
  • 認證和許可

第7章 主要企業簡介

• Cardinal Health
• LeMaitre
• McKesson Medical
• Edwards Lifesciences Corporation
• Axiom Medical Supplies

The future of the global carotid artery shunt kit market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global carotid artery shunt kit market is expected to grow with a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of carotid artery diseases, the growing awareness of stroke prevention, and the increasing advancements in surgical techniques.

• Lucintel forecasts that, within the type category, conventional shunt is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the Carotid Artery Shunt Kit Market

The carotid artery shunt kit market is driven by a mix of emerging trends. These emerging trends are shaping the landscape of the market and determining new products and strategies.

• Minimally Invasive Procedures: Minimally invasive methods have emerged as one of the core trends in the carotid artery shunt kit market. These procedures have benefits such as smaller incisions, quicker recovery times, and fewer complications. Therefore, healthcare providers are increasingly choosing shunt kits that support such techniques. Patients profit from faster recoveries and fewer risks, while doctors can enhance their outcomes in surgery. This development is fueling the need for specialty devices that respond to the increasing trend toward less invasive intervention.
• Technological Innovations: Technological advancements in shunt kits, including real-time tracking and improved accuracy, are revolutionizing the market. The use of advanced materials and technologies, including bioresorbable shunts and blood flow monitoring sensors, is enhancing the success of surgeries. These technologies are designed to enhance patient safety and reduce the risk of complications. With advancements in technology, the market is witnessing more advanced devices which not only improve surgical proficiency but also patient results, resulting in the overall development of the market.
• Aging Population: Aging population, especially in developed nations like the U.S., Japan, and Germany, is one of the main drivers for the growth of the carotid artery shunt kit market. Elderly patients are at a higher risk for cardiovascular disease and thus will more likely need carotid artery procedures. This age group is contributing to the growing demand for successful shunt kits as health systems become increasingly needed for operations. The demographic trend will keep the market in motion over the next few years.
• Move Toward Personalized Medicine: The carotid artery shunt kit industry is witnessing a transition to personalized medicine, where therapy and devices are customized to the specific needs of individual patients. Personalized shunt kits, which are created to fit unique anatomical variations, are becoming more prevalent. These personalized solutions assist in better surgical outcomes by managing distinctive patient conditions as well as minimizing complications. This is complemented by developments in imaging technologies and patient-specific information, allowing medical professionals to make better decisions in the operating room and improve treatment plans.
• Regulatory Changes and Approvals: Regulatory changes are shaping the carotid artery shunt kit market. Tougher regulations in certain markets, including the United States and Europe, guarantee that only the safest and most efficient devices are licensed for use. Conversely, developing markets such as China and India are seeing quicker regulatory approvals, which is speeding up market development. With regulations changing, firms need to comply with global standards, fostering innovation and enhancing the quality and safety of carotid artery shunt kits overall.

These nascent trends-minimally invasive treatments, advances in technology, aging population, personalized care, and regulatory changes-are transforming the carotid artery shunt kit market. The market is more dynamic as continuous innovation continues to improve patient care, surgical results, and general market growth.

Recent Developments in the Carotid Artery Shunt Kit Market

Current trends in the carotid artery shunt kit market indicate increasing emphasis on enhancing the efficacy and safety of carotid artery procedures. Advances in technology and regulatory shifts are driving a wider use of advanced medical devices across different regions.

• Introduction of Advanced Shunt Kits: Recent developments have resulted in the creation of shunt kits with better materials and designs that minimize the risk of complications. The kits have improved blood flow regulation and are more resistant, which enhances surgical results and patient recovery periods. The use of bioresorbable materials and improved shunt structures has greatly minimized risks like infection and thromboembolic complications.
• Growth in Emerging Markets: The carotid artery shunt kit market is growing at a very fast rate in emerging countries like China and India. It is being spurred by enhanced healthcare expenditure and a growing prevalence of cardiovascular diseases. The firms are entering these nations with low-cost, high-performance devices intended to serve local markets. The growth in these nations is a large opportunity for producers to access a previously underserved patient population.
• Advanced Patient Monitoring Features: New carotid artery shunt kits increasingly include real-time monitoring technologies. These advances assist healthcare professionals to monitor blood circulation during the surgical procedure, ensuring fewer chances for complications and increasing the accuracy of surgery. Integrating sensors and other monitoring systems, these kits ensure that surgeons are able to make necessary adjustments in real-time during the process, thus boosting patient safety.
• Rise in Minimally Invasive Surgeries: There has been a significant rise in the use of minimally invasive carotid artery procedures, with the help of improved shunt kit technology. These procedures are linked to quicker recovery, reduced complications, and improved overall results. Consequently, there has been a rise in demand for shunt kits that enable these procedures, resulting in further product developments.
• Regulatory Changes and Approvals: Regulatory agencies across the globe are simplifying new carotid artery shunt kits' approval procedures. This change has accelerated the market launch of sophisticated products. Companies are collaborating very closely with regulatory agencies to comply with local regulations, resulting in accelerated market response and enhanced device safety.

Current trends in the carotid artery shunt kit industry show the concern of the industry to enhance safety, minimize complications, and broaden its reach into new geographic locations. These trends are revolutionizing the market and propelling growth, especially in developing economies and through technology advancements.

Strategic Growth Opportunities in the Carotid Artery Shunt Kit Market

The carotid artery shunt kit market is full of growth opportunities. By recognizing major applications and concentrating on emerging trends, companies can take advantage of the growing demand for efficient surgical solutions.

• Concentrate on Emerging Markets: Growth opportunities exist in emerging markets like China and India because they have growing healthcare infrastructures and increasing rates of cardiovascular diseases. Manufacturers can widen their presence by offering cheap, high-quality shunt kits suitable for these markets. Market growth will be fueled by the growing uptake of sophisticated medical technology in these countries.
• Focus on Minimally Invasive Solutions: Minimally invasive procedures are on the rise, with opportunities for expansion in the carotid artery shunt kit market. Businesses have the potential to design shunt kits specifically for these types of procedures, which come with the benefit of faster recovery and better patient outcomes. As the demand for minimally invasive technology rises, manufacturers need to concentrate on innovation in this area.
• Development of Personalized Medicine: As the demand for personalized medicine grows, there is potential for the creation of shunt kits designed to meet the individualized needs of patients. New technologies like 3D imaging and made-to-measure medical devices may be used to rectify unique anatomical issues and enhance surgical success. Firms that capitalize on this wave will most likely achieve a competitive edge over other companies.
• Collaboration with Healthcare Providers: Working with healthcare institutions, including surgical centers and hospitals, presents the potential to enhance the rate of uptake for carotid artery shunt kits. Collaborations aimed at training, research, and education can enhance the use of new shunt kits and promote effective application in clinics.
• Emphasis on Regulatory Approvals: Getting quicker regulatory approval and complying with global standards presents a considerable growth prospect. By being compliant with strict regulations in major markets like the U.S. and Europe, businesses can gain entry to a greater market and establish confidence with healthcare providers.

Strategic growth prospects in the carotid artery shunt kit market are centered around penetrating emerging markets, emphasizing minimally invasive solutions, individualizing medicine, partnering with healthcare providers, and traversing regulatory environments. By taking advantage of these opportunities, businesses can fuel growth and increase their market share.

Carotid Artery Shunt Kit Market Driver and Challenges

The carotid artery shunt kit market is affected by a number of drivers and challenges such as technological advances, economic pressures, and regulatory demands.

The factors responsible for driving the carotid artery shunt kit market include:

1. Technological Advancements: Technological innovation in medical equipment is a prime growth driver for the market. Advances in materials, including bioresorbable shunts and real-time monitoring, are enhancing outcomes during surgery and minimizing complications. Improved and simpler kits are enabling medical professionals to carry out carotid artery procedures with more accuracy.

2. Aging Population: The ageing population, especially in developed nations, is one of the major drivers for the carotid artery shunt kit market. Elderly people are at a higher risk of cardiovascular diseases, thus requiring more carotid artery surgeries. The rising population of older people is increasing the demand for sophisticated shunt kits to assist these procedures.

3. Increasing Prevalence of Cardiovascular Diseases: Growing occurrence of cardiovascular disease all over the globe is stimulating demand for carotid artery procedures and consequently, shunt kits. An upsurge in conditions such as atherosclerosis and stroke is emphasizing the need for safe surgical interventions. As the cardiovascular disease burden rises across the world, the demand for carotid artery shunt kits grows.

4. Increasing Investments in Healthcare: Growth in healthcare spending in both emerging and developed markets is boosting growth in the carotid artery shunt kit market. When governments are investing in the healthcare infrastructure, there is more focus on enhancing surgical interventions as well as care for patients. This brings forth the demand for cutting-edge medical technologies such as shunt kits.

5. Supportive Regulatory Framework: A positive regulatory framework in countries like the U.S. and Europe is helping to expedite the approval of new medical devices. Regulatory authorities are making efforts to simplify the approval process, which speeds up the release of new and enhanced shunt kits, fueling market growth.

Challenges in the carotid artery shunt kit market are:

1. High Cost of Advanced Devices: The exorbitant price of sophisticated carotid artery shunt kits is a hindrance to market expansion, especially in developing economies. Although the devices provide better results, their steep price restricts access for some patients, making it difficult to achieve widespread adoption. Companies need to prioritize balancing cost and innovation to address a wider patient population.

2. Shortage of Skilled Surgeons: The lack of well-trained surgeons familiar with newer shunt kits is a major challenge. Though newer technologies have made shunt kits easier to use, specialized training is still required to apply the devices. This constraint can hinder the implementation of new technologies, particularly in areas that have limited exposure to trained physicians.

3. Regulatory Barriers: Strict regulatory rules in certain markets can delay the process of approval for new carotid artery shunt kits. Firms have to penetrate difficult regulatory environments to comply and secure entry into a market. This can impede the launch of new products, thus affecting the prospect for growth in such markets.

The carotid artery shunt kit market is influenced by major drivers including technological innovation, aging population, high cardiovascular disease incidence, growing investments in healthcare, and a supportive regulatory landscape. High costs, unavailability of specialized surgeons, and regulatory obstacles are the challenges that need to be overcome to fully realize the market's potential. How these factors interact will dictate the direction of the market's growth.

List of Carotid Artery Shunt Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies carotid artery shunt kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the carotid artery shunt kit companies profiled in this report include-

• Cardinal Health
• LeMaitre
• McKesson Medical
• Edwards Lifesciences Corporation
• Axiom Medical Supplies

Carotid Artery Shunt Kit Market by Segment

The study includes a forecast for the global carotid artery shunt kit market by type, application, and region.

Carotid Artery Shunt Kit Market by Type [Value from 2019 to 2031]:

• Conventional Shunt
• Flow Reversal System

Carotid Artery Shunt Kit Market by Application [Value from 2019 to 2031]:

• Hospital
• Ambulatory Surgery Center
• Others

Carotid Artery Shunt Kit Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Carotid Artery Shunt Kit Market

The carotid artery shunt kit market indicate an increasing focus on improving medical procedures for carotid artery disease. Carotid artery shunting is crucial in avoiding complications like stroke in carotid endarterectomy procedures. carotid artery shunt kit market advancements are aimed at technological advancements, breakthroughs in medical devices, and improving awareness of the advantages of these procedures. The market for the kits is expanding in different geographic regions due to increasing aging population and rising occurrence of cardiovascular ailments. Major economies, including the United States, China, Germany, India, and Japan, are undergoing transformation in market forces.

• United States: Recent improvements in the market for the United States carotid artery shunt kit include increased precise and user-centric devices. These technologies are designed to enhance patient outcomes during procedures by minimizing complications and recovery periods. Also, some healthcare providers are implementing minimally invasive procedures, which have increased the demand for advanced shunt kits. Changes in regulations and an increase in the number of patients needing carotid artery surgery have also fueled market growth. The U.S. market is still a leader, fueled by technological innovation and a strong healthcare infrastructure.
• China: China has witnessed rising demand for the carotid artery shunt kit market, driven mainly by the rising incidence of cardiovascular diseases among its aging population. The nation is experiencing large-scale investments in healthcare infrastructure, which has led to the acceptance of sophisticated medical devices, such as carotid artery shunt kits. Chinese companies are focusing on enhancing the affordability and availability of these devices, making them accessible to a wider market. Additionally, China's regulatory framework is also changing, with the authorities giving quicker approvals to medical devices, which results in greater market expansion and competitiveness.
• Germany: The carotid artery shunt kit market in Germany is marked by intense technological advancement. German companies specialize in making some of the world's most cutting-edge and precise shunt kits, adhering to strict quality standards. The nation's healthcare system facilitates the large-scale use of such technologies, and there is an increasing focus on minimally invasive procedures. The growth of the market is also facilitated by a focus on early diagnosis and preventative care, resulting in more carotid artery surgeries. Additionally, the strong export potential of Germany has helped it become established in overseas markets.
• India: India's market for carotid artery shunt kits is growing on account of enhancement in healthcare facilities and rising incidences of cardiovascular diseases. The aging population coupled with increasing old-age dependency makes carotid artery surgery a necessary treatment requirement, hence triggering demand for shunt kits. The Indian market is also observing international players coming in and promoting new, value-for-money offerings. Yet, price sensitivity and access to trained health professionals pose the challenges, but the outlook is positive in the market as a result of increasing investments in the healthcare sector and awareness.
• Japan: Japan's carotid artery shunt kit market is favored by good quality healthcare services as well as developed technological infrastructure. The nation has experienced a trend towards more efficient and effective shunt kits favoring minimally invasive procedures. With the aging population of Japan, the demand for carotid artery procedures has increased, making the market grow. The government support for healthcare research and innovation has also enhanced the rate at which cutting-edge medical devices are developed. Japan remains a major global market player due to its established healthcare industry and innovation-led strategy.

Features of the Global Carotid Artery Shunt Kit Market

Market Size Estimates: Carotid artery shunt kit market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Carotid artery shunt kit market size by type, application, and region in terms of value ($B).

Regional Analysis: Carotid artery shunt kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the carotid artery shunt kit market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the carotid artery shunt kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the carotid artery shunt kit market by type (conventional shunt and flow reversal system), application (hospital, ambulatory surgery center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Carotid Artery Shunt Kit Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Carotid Artery Shunt Kit Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Carotid Artery Shunt Kit Market by Type
  • 3.3.1: Conventional Shunt
  • 3.3.2: Flow Reversal System
• 3.4: Global Carotid Artery Shunt Kit Market by Application
  • 3.4.1: Hospital
  • 3.4.2: Ambulatory Surgery Center
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Carotid Artery Shunt Kit Market by Region
• 4.2: North American Carotid Artery Shunt Kit Market
  • 4.2.1: North American Market by Type: Conventional Shunt and Flow Reversal System
  • 4.2.2: North American Market by Application: Hospital, Ambulatory Surgery Center, and Others
• 4.3: European Carotid Artery Shunt Kit Market
  • 4.3.1: European Market by Type: Conventional Shunt and Flow Reversal System
  • 4.3.2: European Market by Application: Hospital, Ambulatory Surgery Center, and Others
• 4.4: APAC Carotid Artery Shunt Kit Market
  • 4.4.1: APAC Market by Type: Conventional Shunt and Flow Reversal System
  • 4.4.2: APAC Market by Application: Hospital, Ambulatory Surgery Center, and Others
• 4.5: ROW Carotid Artery Shunt Kit Market
  • 4.5.1: ROW Market by Type: Conventional Shunt and Flow Reversal System
  • 4.5.2: ROW Market by Application: Hospital, Ambulatory Surgery Center, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Carotid Artery Shunt Kit Market by Type
  • 6.1.2: Growth Opportunities for the Global Carotid Artery Shunt Kit Market by Application
  • 6.1.3: Growth Opportunities for the Global Carotid Artery Shunt Kit Market by Region
• 6.2: Emerging Trends in the Global Carotid Artery Shunt Kit Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Carotid Artery Shunt Kit Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Carotid Artery Shunt Kit Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Cardinal Health
• 7.2: LeMaitre
• 7.3: McKesson Medical
• 7.4: Edwards Lifesciences Corporation
• 7.5: Axiom Medical Supplies